|

DELINEATE-Prospective

RECRUITINGSponsored by Columbia University
Actively Recruiting
SponsorColumbia University
Started2026-04-15
Est. completion2027-10-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

Heart disease is the leading cause of death in the United States, and echocardiography (or "echo") is the most common way doctors look at the heart. Echo is safe, painless, and can detect major heart problems, including weak heart pumping and valve disease. Valve disease, especially aortic stenosis (narrowing) and mitral regurgitation (leakage), is common in older adults but often goes undiagnosed. While echo is the main tool for finding valve problems, it takes time, requires expert training, and results can vary between readers. Recent advances in artificial intelligence (AI), especially deep learning (DL), have shown promise in automatically analyzing heart images. However, past research hasn't fully tackled key echo techniques-like color Doppler and spectral Doppler-that are crucial for measuring how blood moves through heart valves. AI tools also face challenges in being used in everyday medical practice because of workflow issues, lack of real-world testing, and concerns about how the algorithms make decisions. At Columbia University Irving Medical Center, researchers have built a large database of heart tests over the last six years and developed AI programs to analyze echocardiograms. The current study will test whether providing AI analysis to cardiologists in real time during echo reading can make the process faster and more consistent.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Attending cardiologist employed by Columbia University, ColumbiaDoctors, or NewYork Presbyterian Hospital who reads transthoracic echocardiograms in the Columbia echocardiography laboratory
* Provided informed consent to take part in the questionnaires or pivotal study

Exclusion Criteria:

* Physician in training (cardiology fellow or advanced imaging fellow)

Conditions7

Aortic RegurgitationAortic StenosisHeart DiseaseMitral Regurgitation (MR)Tricuspid Regurgitation (TR)Valve Disease, AorticValvular Heart Disease

Locations1 site

Columbia University Irving Medical Center
New York, New York, 10032
Jeffrey Ruhl, MS570-713-7815hvx9001@nyp.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.